Status:
COMPLETED
Efficiency And Tolerance Of Hazelnut Oral Immunotherapy Protocol In Hazelnut Allergic Children
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Allergy, Nut
Pediatric ALL
Eligibility:
All Genders
1-18 years
Brief Summary
Prevalence of food allergy in the world has been inscreasing in recent years. Among nut allergy, hazelnut allergy is the most widespread in Europe and particularly in France. The current treatment for...
Eligibility Criteria
Inclusion
- Aged Under eighteen years old
- Hazelnut allergy (clinically and biologically)
- Under IOT hazelnut protocol in Pneumo/allergology-paediatric departement of the Mother and Child hospital in Bron
Exclusion
- Lack of consent to be included in the study (by their parents)
- Age \> 18 years old
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2021
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04841850
Start Date
March 1 2021
End Date
May 15 2021
Last Update
September 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pneumology allergology-paediatric department of the Mother and Child Hospital
Bron, France, 69500